Company: ARTL
Filing Date: 2025-11-17
Form Type: S-1
Source: 0001640334-25-002154
Chunk: 17

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-17
Form: S-1
Chunk 17
---
 certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our Common Stock held by non-affiliates equals or exceeds $250 million as of the end of that year’s second fiscal quarter, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our Common Stock held by non-affiliates equals or exceeds $700 million as of the end of that year’s second fiscal quarter. |

| 7 |

| The Offering                                                  |                                                                                                                                                                                                                                                                                                              |
| Shares of Common Stock Offered by the Selling Securityholders | 899,972 shares of Common Stock, consisting of: (i) 215,292 shares of Common Stock issuable upon the conversion of the Notes, (ii) 246,498 shares of Common Stock issuable upon the exercise of the $6.24 Warrants, and (iv) 438,182 shares of Common Stock issuable upon the exercise of the $3.40 Warrants. |
| Use of proceeds                                               | We will not receive any proceeds from any sale of the shares being offered for sale by the Selling Securityholders. We will, however, receive the net proceeds of any Warrants exercised for cash. See “Use of Proceeds” for additional information                                                          |
| Dividend policy                                               | We have never declared or paid any cash dividends on our shares of Common Stock. We do not anticipate paying any cash dividends in the foreseeable future.                                                                                                                                                   |
| Risk factors                                                  | You should carefully consider the risk factors described in the section of this prospectus entitled “Risk Factors,” together with all of the other information included in this prospectus, before deciding to purchase our shares of Common Stock.                                                          |
| Market and trading symbol                                     | Our shares of Common Stock are traded on the Nasdaq Capital Market under the symbol “ARTL.”                                                                                                                                                                                                                  |

| 8 |

<div align='center'>RISK FACTORS</div>

An investment in our securities involves a high degree of risk. Our business, financial condition or results of operations could be materially and adversely affected by any of these risks. If any of these risks occur, the value of our shares of Common Stock and our other securities may decline. Before making your investment decision, you should carefully consider the risks together with all of the other information contained or incorporated by reference in this prospectus, including any risks